BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 176 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,104,000 | +3.0% | 86,684 | -0.7% | 0.01% | 0.0% |
| Q2 2022 | $12,725,000 | +95.0% | 87,333 | +58.7% | 0.01% | +150.0% |
| Q1 2022 | $6,526,000 | -9.5% | 55,034 | +5.2% | 0.00% | 0.0% |
| Q4 2021 | $7,209,000 | +6.1% | 52,313 | +7.0% | 0.00% | 0.0% |
| Q3 2021 | $6,793,000 | +89.8% | 48,898 | +32.6% | 0.00% | +100.0% |
| Q2 2021 | $3,579,000 | +55.0% | 36,867 | +9.2% | 0.00% | 0.0% |
| Q1 2021 | $2,309,000 | -19.7% | 33,775 | +0.7% | 0.00% | 0.0% |
| Q4 2020 | $2,876,000 | +31.3% | 33,553 | -0.4% | 0.00% | 0.0% |
| Q3 2020 | $2,190,000 | -2.0% | 33,681 | +10.2% | 0.00% | 0.0% |
| Q2 2020 | $2,234,000 | +144.4% | 30,559 | +13.8% | 0.00% | 0.0% |
| Q1 2020 | $914,000 | -46.6% | 26,859 | -14.6% | 0.00% | 0.0% |
| Q4 2019 | $1,711,000 | +34.4% | 31,437 | +3.0% | 0.00% | 0.0% |
| Q3 2019 | $1,273,000 | +82.4% | 30,515 | +91.2% | 0.00% | – |
| Q2 2019 | $698,000 | -9.7% | 15,956 | +6.2% | 0.00% | – |
| Q1 2019 | $773,000 | +294.4% | 15,019 | +184.2% | 0.00% | – |
| Q4 2018 | $196,000 | +12.6% | 5,284 | +14.1% | 0.00% | – |
| Q3 2018 | $174,000 | -0.6% | 4,632 | +4.9% | 0.00% | – |
| Q2 2018 | $175,000 | +20.7% | 4,417 | -21.5% | 0.00% | – |
| Q1 2018 | $145,000 | +101.4% | 5,626 | +111.3% | 0.00% | – |
| Q4 2017 | $72,000 | -39.5% | 2,663 | -15.4% | 0.00% | – |
| Q3 2017 | $119,000 | +72.5% | 3,147 | +13.7% | 0.00% | – |
| Q2 2017 | $69,000 | – | 2,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
| RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
| ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
| Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
| Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |